arrow
P

Prajakta Warang

ica hn school of medicine at mount sinai
H指数:9
被引数:978

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human monoclonal antibodies targeting A35 protect from death caused by mpox

靶向A35的人源单克隆抗体可防止猴痘病毒引起的死亡

Cell
IF42.5
2025-08-260
OAAI
A ventilated perfused lung model platform to dissect the response of the lungs to viral infection

一种通气血流灌注的肺模型平台,用于解析肺部对病毒感染的应答

2025-04-240
PRE
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models

基于NDV的多价黏膜疫苗在动物模型中提供针对SARS-CoV-2变体的交叉反应性免疫应答

2025-03-170
OA
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models

在COVID-19和流感小鼠疫苗接种模型中,FcRn拮抗作用对疫苗诱导的针对病毒攻击的保护性免疫应答的影响

2025-03-030
OAAI
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA
2024-12-010
OAAI
Plitidepsin as an Immunomodulator against Respiratory Viral Infections

Plitidepsin作为抗呼吸道病毒感染的免疫调节剂

2024-02-280
PRE
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
MBIO
IF4.7
2024-02-142
OAAI
Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity
SMALL
IF12.1
2023-10-229
OA
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

多组分鼻内佐剂用于年轻和老年小鼠的粘膜和持久全身SARS-CoV-2免疫

2023-06-296
OAAI
SARS-CoV-2 Ancestral and Variant of Concern Breakthrough infections boost both cross-reactive cellular and humoral immune responses in mRNA-vaccinated Hamsters.
2023-05-010
OA
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants
MED
IF11.8
2022-10-018
OAAI